← Back to all signals

BTSG BrightSpring Health Services, Inc.

Last updated: Nov 16, 2026

—

Execution Consistency

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Bought back stock in 2/4 quarters. Q3 2026: $0M, Q2 2026: $60M, Q1 2026: $60M, Q3 2025: $0M

🐻

Execution Acceleration

Is the most recent quarter's buyback spend more than 15% above the trailing average?

Latest quarter $0M vs trailing avg $40M (-100%)

🐂

Buyback vs FCF

What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.

Buyback $120M / FCF $13M = 914% of FCF

—

Buyback Intensity

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Missing shares repurchased or outstanding data

🐻

Insider Buying

Are officers and directors buying stock with their own money on the open market?

No insider open-market purchases in the last 12 months

—

Insider-Buyback Convergence

Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.

Need both buyback and insider purchase data

🐻

Insider Net Direction

Over the last 90 days, are insiders net buyers or net sellers on the open market?

Insiders bought $0M, sold $1M in the last 90 days (net selling)

🚩

Red Flag

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

Company buying back stock while insiders sold 3362066111.6x more than bought. 2 C-suite officers among sellers

  • Greenwell Scott A. (President, PharMerica) sold 15,099 shares on 2026-09-14
  • Phipps Jennifer A (Chief Financial Officer) sold 35,000 shares on 2026-06-05
  • Phipps Jennifer A (Chief Financial Officer) sold 35,000 shares on 2026-03-04